Pss42 - Secukinumab Significantly Reduces Psoriasis-Related Work Impairment and Indirect Costs Compared to Ustekinumab and Etanercept in Morocco

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2542
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pss41 - Secukinumab Significantly Reduces Psoriasis-Related Work Impairment and Indirect Costs Compared to Ustekinumab and Etanercept in Tunisia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Modulation of Inflammatory Gene Transcripts in Psoriasis Vulgaris: Differences Between Ustekinumab and Etanercept

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Impact of HS on Work Loss, Indirect Costs and Income

British Journal of Dermatology
DermatologyMedicine
2019English

Pms46 Impact of Etanercept on Work and Activity Impairment in Employed Patients With Moderate to Severe Rheumatoid Arthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Risankizumab vs. Ustekinumab for Plaque Psoriasis

British Journal of Dermatology
DermatologyMedicine
2019English

Psy86 - Higher Levels of Skin Clearance Are Associated With Decreased Indirect Costs Related to Productivity Loss in Patients With Moderate-To-Severe Plaque Psoriasis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pss17 - Cost Per Responder Analysis of Brodalumab Compared With Ustekinumab in the Treatment of Moderate-To-Severe Plaque Psoriasis in Canada

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Efficacy and Safety of Ustekinumab in Patients With Psoriasis and Psoriatic Arthritis

Clinical pharmacology and therapy
2018English

Pss35 - Secukinumab Versus Ustekinumab for the Treatment of Psoriasis: A 52-Week Cost Per Responder Analysis From the Portuguese Payer Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy